New Zealand’s Centre for Adverse Reactions Monitoring is now transitioning to a new digital system for collecting and storing adverse drug reaction reports in the country, retiring its almost 60-year-old database.
The centre has worked with medicines regulator Medsafe in developing the new digital database, whose early version went online in December last year to support the processing of ADRs for COVID-19 and monkeypox vaccines.
Following…